817172-30-8

Basic information

• Product Name: 2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL
• Synonyms: 2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL;2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HYDROCHLORIDE
• CAS NO: 817172-30-8
• Molecular Formula: C13H11Cl2N3
• Molecular Weight: 280.15
• Mol File: 817172-30-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL(817172-30-8)
• EPA Substance Registry System: 2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL(817172-30-8)

Safety Data

• Hazardous Substances Data: 817172-30-8(Hazardous Substances Data)

Usage

Chemical Class

2-(4-CHLORO-PHENYL)-1H-BENZOIMIDAZOL-5-YLAMINE HCL belongs to the benzimidazole class of compounds.

Physical Appearance

It is a white to off-white crystalline solid.

Common Uses

It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals.

Biological Activities

The compound has been found to exhibit various biological activities, including anti-inflammatory, anti-cancer, and antimicrobial properties.

Value in Drug Development

It is a valuable candidate for drug development due to its potential pharmacological properties.

Importance in Medicinal Chemistry

Its unique structure and potential pharmacological properties make it a promising compound for further research and development in the field of medicinal chemistry.

Relevant articles and documents

Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production

Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I): in which:G1 and G2 are hydrogen, halogen, hydroxyl, C1-C4 alkoxy, C1-C4 alkyl, and an amidino substituent of formula Q, provided that, for each compound of formula (I), only one of the two substituents G1 or G2 is an amidino substituent of formula Q: and in which the substituents W, Y and X are combined to form 9- or 10-membered bicyclic heteroaromatic derivatives containing up to 2 hetero atoms in the same ring; andZ is an aryl or heteroaryl group, a linear or branched C1-C6 alkyl or alkenyl chain, a C1-C4 alkyl-aryl group or a C1-C4 alkyl-heteroaryl group.

Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production

Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I): in which: G1 and G2 are hydrogen, halogen, hydroxyl, C1-C4 alkoxy, C1-C4 alkyl, and an amidino substituent of formula Q, provided that, for each compound of formula (I), only one of the two substituents G1 or G2 is an amidino substituent of formula Q: and in which the substituents W, Y and X are combined to form 9- or 10-membered bicyclic heteroaromatic derivatives containing up to 2 hetero atoms in the same ring; and Z is an aryl or heteroaryl group, a linear or branched C1-C6 alkyl or alkenyl chain, a C1-C4 alkyl-aryl group or a C1-C4 alkyl-heteroaryl group.